rs112651246 - TIMM29 - SMARCA4
Magnitude 2.2 · 1 study on file
Reported associations
-
Uncovering myocardial infarction genetic signatures using GWAS exploration in Saudi and European cohorts - Unknown journal (n.d.) · Unknown authors · PubMed 38072966
ABSTRACT: Genome-wide association studies (GWAS) have yielded significant insights into the genetic architecture of myocardial infarction (MI), although studies in non-European populations are still lacking. Saudi Arabian cohorts offer an opportunity to discover novel genetic variants impacting disease risk due to a high rate of consanguinity. Genome-wide genotyping (GWG), imputation and GWAS followed by meta-analysis were performed based on two independent Saudi Arabian studies comprising 3950 MI patients and 2324 non-MI controls. Meta-analyses were then performed with these two Saudi MI studies and the CardioGRAMplusC4D and UK BioBank GWAS as controls. Meta-analyses of the two Saudi MI studies resulted in 17 SNPs with genome-wide significance. Meta-analyses of all 4 studies revealed 66 l
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
Genetic myocardial infarction risk from rs112651246 Moderate
rs112651246 variant increases myocardial infarction risk (OR 1.046, genome-wide significant, n=640,268)
Discuss genetic contribution to MI risk during cardiovascular assessment
Screening
-
Baseline cardiovascular risk assessment Moderate
Genetic predisposition to myocardial infarction warrants evaluation of modifiable cardiovascular risk factors